Colon Flor 4
Research Summary
AI-generated summary
Xerox (XRX) CLO Colon Flor Converts 280,899 RSUs
What Happened
- Colon Flor, Chief Legal Officer and Corporate Secretary of Xerox Holdings Corp (XRX), reported a conversion/exercise of a derivative on 2026-05-20 that resulted in 280,899 shares at a reported price of $0.00 and $0 proceeds. The Form 4 (filed 2026-05-22) lists the transaction under code M (exercise or conversion of derivative). This entry reflects settlement/conversion of awards rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-05-20; Form 4 filed: 2026-05-22 (timely filing).
- Reported shares involved: 280,899 shares; reported price: $0.00; reported proceeds: $0.
- Shares owned after transaction: not specified in the provided excerpt — see the full Form 4 for total beneficial ownership.
- Footnote: F1 indicates these were restricted stock units (RSUs) that vest in nine installments, with one-third vesting on March 11, 2027 and the remainder vesting equally over the next eight quarters.
- Transaction code M denotes an exercise or conversion of a derivative (here, RSU settlement/conversion). No sale proceeds or open-market sale is shown.
Context
- For retail investors: a $0 price on a conversion usually means RSUs or similar awards were settled into shares rather than a cash purchase. This is not a sale signaling a change in insider market sentiment; it documents award settlement/vesting mechanics. Check the full filing for details on total holdings and any subsequent sales or tax-withholding transactions.